Post by The Walden Group, Inc.

Medtronic to Acquire Intersect ENT Medtronic plc (Nasdaq: MDT), a $30.1b Ireland-based producer of devices used in cardiovascular, neuroscience, surgical, and diabetes management applications, is acquiring Intersect ENT (Nasdaq: XENT), a developer of an ENT implant that releases steroids during sinus surgery to manage inflammation and a virtual surgical guidance platform. https://lnkd.in/eP2UxRYR